Advancing Analytical Methods in Clinical Stages with Commercial Considerations
Time: 12:45 pm
day: Conference Day Two
Details:
- Continuous Refinement: Emphasize the iterative optimization of analytical methods throughout clinical phases to address emerging challenges and improve assay performance and being challenged by resource limitation and complexity of the product
- Improving in house capabilities: Discuss the integration of new technologies into analytical workflows to enhance efficiency and scalability, reduce cost and improve vein to vein time
- Regulatory Adaptation: Highlight the importance of regulatory compliance and adapting methods to meet evolving requirements, emphasizing proactive engagement and adherence to GMP standards for product release and post-market surveillance
